Northstar Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.92M | Buy |
24,246
+981
| +4% | +$113K | 0.41% | 43 |
|
|
2025
Q4 | $2.45M | Sell |
23,265
-180
| -0.8% | -$16.9K | 0.33% | 45 |
|
|
2025
Q3 | $1.97M | Sell |
23,445
-70
| -0.3% | -$5.77K | 0.29% | 50 |
|
|
2025
Q2 | $1.86M | Sell |
23,515
-1,314
| -5% | -$104K | 0.29% | 51 |
|
|
2025
Q1 | $2.23M | Buy |
24,829
+1,759
| +8% | +$164K | 0.36% | 48 |
|
|
2024
Q4 | $2.3M | Buy |
23,070
+265
| +1% | +$27.3K | 0.38% | 44 |
|
|
2024
Q3 | $2.59M | Hold |
22,805
| – | – | 0.45% | 40 |
|
|
2024
Q2 | $2.82M | Sell |
22,805
-717
| -3% | -$92.4K | 0.53% | 36 |
|
|
2024
Q1 | $3.1M | Sell |
23,522
-460
| -2% | -$56.7K | 0.61% | 36 |
|
|
2023
Q4 | $2.61M | Sell |
23,982
-3,450
| -13% | -$358K | 0.57% | 37 |
|
|
2023
Q3 | $2.82M | Sell |
27,432
-50
| -0.2% | -$5.39K | 0.67% | 34 |
|
|
2023
Q2 | $3.17M | Buy |
27,482
+150
| +0.5% | +$17K | 0.74% | 32 |
|
|
2023
Q1 | $2.91M | Sell |
27,332
-580
| -2% | -$62.6K | 0.75% | 35 |
|
|
2022
Q4 | $3.1M | Buy |
27,912
+2,920
| +12% | +$298K | 0.88% | 29 |
|
|
2022
Q3 | $2.15M | Hold |
24,992
| – | – | 0.64% | 35 |
|
|
2022
Q2 | $2.28M | Sell |
24,992
-76
| -0.3% | -$6.74K | 0.66% | 34 |
|
|
2022
Q1 | $2.06M | Sell |
25,068
-131
| -0.5% | -$10.3K | 0.49% | 45 |
|
|
2021
Q4 | $1.93M | Sell |
25,199
-18
| -0.1% | -$1.43K | 0.46% | 49 |
|
|
2021
Q3 | $1.89M | Buy |
25,217
+1,750
| +7% | +$133K | 0.49% | 50 |
|
|
2021
Q2 | $1.82M | Sell |
23,467
-1,310
| -5% | -$97.4K | 0.48% | 53 |
|
|
2021
Q1 | $1.82M | Buy |
24,777
+477
| +2% | +$35.2K | 0.51% | 47 |
|
|
2020
Q4 | $1.9M | Sell |
24,300
-828
| -3% | -$63.3K | 0.58% | 44 |
|
|
2020
Q3 | $1.99M | Buy |
25,128
+3,485
| +16% | +$273K | 0.69% | 39 |
|
|
2020
Q2 | $1.6M | Buy |
21,643
+4,889
| +29% | +$368K | 0.64% | 41 |
|
|
2020
Q1 | $1.23M | Sell |
16,754
-356
| -2% | -$28K | 0.56% | 47 |
|
|
2019
Q4 | $1.49M | Sell |
17,110
-181
| -1% | -$14.9K | 0.57% | 47 |
|
|
2019
Q3 | $1.39M | Sell |
17,291
-483
| -3% | -$38.7K | 0.58% | 48 |
|
|
2019
Q2 | $1.42M | Buy |
17,774
+201
| +1% | +$15.4K | 0.6% | 43 |
|
|
2019
Q1 | $1.4M | Sell |
17,573
-658
| -4% | -$49.2K | 0.62% | 40 |
|
|
2018
Q4 | $1.33M | Sell |
18,231
-760
| -4% | -$53.7K | 0.68% | 41 |
|
|
2018
Q3 | $1.28M | Sell |
18,991
-182
| -0.9% | -$11.6K | 0.59% | 43 |
|
|
2018
Q2 | $1.11M | Sell |
19,173
-452
| -2% | -$25.5K | 0.57% | 48 |
|
|
2018
Q1 | $1.02M | Sell |
19,625
-1,189
| -6% | -$64.2K | 0.53% | 51 |
|
|
2017
Q4 | $1.12M | Buy |
20,814
+7,079
| +52% | +$392K | 0.59% | 44 |
|
|
2017
Q3 | $839K | Buy |
13,735
+286
| +2% | +$17.3K | 0.48% | 54 |
|
|
2017
Q2 | $822K | Buy |
13,449
+58
| +0.4% | +$3.53K | 0.51% | 56 |
|
|
2017
Q1 | $811K | Buy |
13,391
+60
| +0.5% | +$3.64K | 0.54% | 54 |
|
|
2016
Q4 | $749K | Buy |
13,331
+162
| +1% | +$9.48K | 0.52% | 52 |
|
|
2016
Q3 | $784K | Buy |
13,169
+61
| +0.5% | +$3.57K | 0.56% | 48 |
|
|
2016
Q2 | $721K | Buy |
13,108
+64
| +0.5% | +$3.41K | 0.54% | 53 |
|
|
2016
Q1 | $659K | Buy |
13,044
+82
| +0.6% | +$4.02K | 0.5% | 56 |
|
|
2015
Q4 | $653K | Buy |
12,962
+87
| +0.7% | +$4.39K | 0.52% | 54 |
|
|
2015
Q3 | $616K | Buy |
12,875
+74
| +0.6% | +$3.93K | 0.5% | 57 |
|
|
2015
Q2 | $695K | Buy |
12,801
+73
| +0.6% | +$4.09K | 0.53% | 56 |
|
|
2015
Q1 | $698K | Buy |
12,728
+65
| +0.5% | +$3.68K | 0.54% | 53 |
|
|
2014
Q4 | $686K | Buy |
+12,663
| New | +$706K | 0.54% | 53 |
|
Other funds holding MRK
VCM
VPM
Northstar Group's MRK Position: Q1 2026 in Review
Northstar Group increased its Merck (MRK) stake by 4.2% in Q1 2026, buying an estimated $113K and bringing the position to 24,246 shares worth $2.92M. The position accounts for 0.41% of the portfolio, ranked #43.
Northstar Group first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $3.17M in Q2 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Northstar Group held 24,246 shares of Merck worth $2.92M as of Q1 2026.
- Northstar Group bought 981 Merck shares in Q1 2026, an estimated $113K.
- Merck made up 0.41% of Northstar Group's portfolio in Q1 2026, its #43 holding.
- Northstar Group first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
- Northstar Group's Merck position peaked at $3.17M in Q2 2023.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Northstar Group's 13F filing for Q1 2026, filed 28 Apr 2026.